Clinical Trial Update: JS212 Combination Therapies in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for JS212 combination therapies in metastatic colorectal cancer; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• JS212

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING